-

05:55:54 AM

Latest AEMD Stock Market News

AEMD - Aethlon Medical Inc

06/10/21 9:10 AM

Nasdaq : AEMD

Aethlon Medical Announces $12.425 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Aethlon Medical, Inc. (Nasdaq:AEMD), a medical device technology company focused on unmet needs in global health, today announced that it has entered into a definitive agreement with a single institutional investor for the purchase in a registered direct

RHEA-AI

neutral

06/03/21 8:01 AM

Nasdaq : AEMD

Aethlon Medical Publishes Case Studies of Two Critically Ill COVID-19 Patients Treated with the Hemopurifier®

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced the publication of a pre-print manuscript highlighting two case studies of critically ill COVID-19 patients treated with the

RHEA-AI

neutral

03/01/21 8:02 AM

Nasdaq : AEMD

Aethlon Medical to Participate in Two Upcoming Healthcare Investor Conferences

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that the company will participate in the H.C. Wainwright Global Life Sciences Virtual Conference on March 9-10, 2021, and the

RHEA-AI

neutral

02/10/21 4:15 PM

Nasdaq : AEMD

Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device therapeutic company focused on developing products to diagnose and treat life and organ threatening diseases, today reported financial results for its third quarter ended December 31, 2020 and provided

RHEA-AI

neutral

02/04/21 8:02 AM

Nasdaq : AEMD

Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 10, 2021

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial results for its third quarter fiscal year 2021, ended December 31, 2020, at 4:15 p.m. EST on

RHEA-AI

neutral

01/06/21 8:02 AM

Nasdaq : AEMD

Aethlon Medical Expands Leadership Team with Appointment of Chief Business Officer and Chief Medical Officer

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic medical device and technology company focused on unmet needs in viral diseases, oncology and inflammation, today announced the expansion of its executive team with two key appointments: Guy Cipriani as

RHEA-AI

neutral

01/04/21 8:02 AM

Nasdaq : AEMD

Aethlon Medical to Present at the H.C. Wainwright BioConnect 2021 Conference

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic medical device and technology company focused on unmet needs in viral diseases, oncology and inflammation, today announced that the company will participate in the virtual H.C. Wainwright BioConnect 2021

RHEA-AI

neutral

12/16/20 8:02 AM

Nasdaq : AEMD

Aethlon Medical Announces First Patient Treated in First-in-Human Clinical Trial of HEMOPURIFIER® in Head and Neck Cancer

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic medical device and technology company focused on unmet needs in viral diseases, oncology and inflammation, announced today that the first patient has been treated in the Company's first-in-human Early

RHEA-AI

very positive

11/03/20 8:01 AM

Nasdaq : AEMD

Aethlon Announces Appointment of Charles J. Fisher, Jr., M.D. as Chief Executive Officer

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical technology company focused on developing products to diagnose and treat life and organ threatening diseases, announced today the appointment of Charles J. Fisher, Jr., M.D., as Chief Executive Officer, effective

RHEA-AI

very positive

10/28/20 4:15 PM

Nasdaq : AEMD

Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on developing products to diagnose and treat life and organ threatening diseases, today reported financial results for its second quarter ended September 30, 2020 and provided

RHEA-AI

neutral

AEMD Data

industryAnalytical Laboratory Instrument Manufacturing
websitewww.aethlonmedical.com
ceoTimothy Rodell
security nameAethlon Medical Inc
issue typecs
sectorManufacturing
sic code3826
employees
tagsHealth Technology,Medical Specialties,Manufacturing,Analytical Laboratory Instrument Manufacturing
address9635 Granite Ridge Dr Ste 100
address2
stateCalifornia
citySan Diego
zip92123
countryUS
phone18584597800

AEMD Description:

Aethlon is focused on addressing unmet needs in global health. The Aethlon Hemopurifier is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. In cancer, the Hemopurifier is designed to deplete the presence of circulating tumor-derived exosomes that promote immune suppression.